The diversity and evolution of the class A OXY -lactamase from Klebsiella oxytoca were investigated and compared to housekeeping gene diversity. The entire bla OXY coding region was sequenced in 18 clinical isolates representative of the four K. oxytoca -lactamase gene groups bla OXY-1 to bla OXY-4 and of two new groups identified here, bla OXY-5 (with four isolates with pI 7.2 and one with pI 7.7) and bla OXY-6 (with four isolates with pI 7.75 and three with pI 8.1). Genes bla OXY-5 and bla OXY-6 showed 99.8% within-group nucleotide similarity but differed from each other by 4.2% and from bla OXY-1 , their closest relative, by 2.5% and 2.9%, respectively. Antimicrobial susceptibility to -lactams was similar among OXY groups. Nucleotide sequence diversity of the 16S rRNA (1,454 bp), rpoB (940 bp), gyrA (383 bp), and gapDH (573 bp) genes was in agreement with the -lactamase gene phylogeny. Strains with bla OXY-1 , bla OXY-2 , bla OXY-3 , bla OXY-4 , and bla OXY-6 genes formed five phylogenetic groups, named KoI, KoII, KoIII, KoIV, and KoVI, respectively. Isolates harboring bla OXY-5 appeared to represent an emerging lineage within KoI. We estimated that the bla OXY gene has been evolving within K. oxytoca for approximately 100 million years, using as calibration the 140-million-year estimation of the Escherichia coli-Salmonella enterica split. These results show that the bla OXY gene has diversified along K. oxytoca phylogenetic lines over long periods of time without concomitant evolution of the antimicrobial resistance phenotype.Klebsiella oxytoca is an important opportunistic pathogen causing serious infections in hospitalized patients, including neonates (16,19,28). K. oxytoca is naturally resistant to aminoand carboxy-penicillins (21), a phenotype due to the constitutive expression of a chromosomal class A -lactamase (1), first called K1 (7,20) or KOXY (26) and now OXY (12). Due to the hyperproduction of the chromosomal -lactamase, up to 10 to 20% of K. oxytoca strains (22) can show high-level resistance to certain expanded-spectrum cephalosporins (ceftriaxone and cefotaxime) and aztreonam (8). Up mutations in the promoter sequence of the genes are responsible for this phenotype (9-11). Overproducers of OXY enzymes are commonly resistant to all combinations of -lactams with -lactam inhibitors (21).Sequence diversity of the K. oxytoca chromosomal -lactamase gene and the existence of discrete groups of OXY enzymes have been described. Fournier et al. (12) found a variant (bla OXY-2 ) of the chromosomal -lactamase gene that differed from bla OXY-1 (1) by 12.7% in nucleotide sequence. It was suggested, based on colony hybridization, that the -lactamase genes of K. oxytoca could be classified into two groups (OXY-1 and OXY-2), each representing approximately half of the clinical isolates (12). Recently, Granier et al. (14) identified two additional sequence variants, defined as bla OXY-3 and bla , each found in a single strain so far. Gene bla shares 85 and 84% similarity with bla OXY-1 and bla OXY...